Help the epidemic prevention and control!Fosun Pharmaceutical emergency deployment of the first domestic new crown oral medicament to arrive in many places

Recently, the epidemic in Hainan, Henan, Xinjiang and other places in China has been released, and the situation of the prevention and control of the epidemic is still severe and complicated. The reporter learned from Fosun Pharmaceutical that Fosun Pharmaceuticals combined with real creatures actively responded to the needs of governments in various localities, and emergencyly prepared anti -new crown pneumonia small molecules oral drugs Azf's fixed aid in many places in the country. Recently, Henan, Hainan, Xinjiang, etc. The ground helps to build a stubborn prevention and control barrier.

Azf's fixed film is my country's first approval to have completely independent intellectual property rights and global patented type 1.1 category of anti -new crown pneumonia. According to the key III registered clinical trials that support their listing applications, Azf's fixed tablets can significantly shorten the moderate new type of coronary virus infection with pneumonia, and increase the proportion of patients with improved clinical symptoms, and achieve the results of clinical excellent efficiency. In terms of inhibiting the role of new coronal virus, Azf's fixed tablet can inhibit the activity of the new coronal virus. In addition, from the perspective of security, the overall tolerance of Azf's fixed sets is good. The incidence of adverse events has no statistical differences with the placebo group and the risk of the subject.

According to the price of medical insurance networks in various places, Azf's fixed price is priced at 270 yuan per bottle, 35 tablets per bottle, and 1 mg per piece.

On July 20, 2021, the State Drug Administration has attached conditions to approve the real biotechnology Azf fixed tablet and other reverse-transliterase inhibitors for adult HIV-1 infection patients with high virus load. On July 25, 2022, the Emergency Conditions of the State Drug Administration approved the real creature Azf fixed tablet to increase the application of new coronary pneumonia treatment indications for the treatment of adult patients with COVID-19). On August 9th, the General Office of the National Health and Health Commission and the Office of the State Administration of Traditional Chinese Medicine issued a notice saying that the approved opinions of the application for the treatment of new coronary virus pneumonia are approved in accordance with the conditions of the State Drug Administration. Improve the new type of coronary virus pneumonia antiviral treatment plan. After research, the medicine is included in the "New Coronatte Pneumonia Pneumonia Diagnosis and Treatment Plan (Ninth Edition)". According to the "diagnosis and treatment plan", Azf's fixed tablet is used to treat adult patients with COVID-19). The amount of usage is swallowed by the entire space, 5mg each time, once a day, the course of treatment is not more than 14 days.

On July 25, Fosun Pharmaceutical announced a strategic cooperation with Henan True Biotechnology Co., Ltd., which will jointly develop and be exclusively commercialized by the Holding subsidiary Fosun Pharmaceutical Industry. Fosun Pharmaceutical will continue to pay close attention to the situation of this round of epidemic, and has made corresponding commercial deployments, and cooperates with partners to ensure the production and supply of drugs, and effectively meet the needs of the first -line prevention and control of the epidemic.

Responsible editor Xu Ling

Text Yang Zhenying

- END -